Your session is about to expire
← Back to Search
Q4W GMA301 IV injections (300 mg) for Pulmonary Arterial Hypertension
Study Summary
This trial is testing a new drug to see if it's safe and effective for treating pulmonary arterial hypertension.
- Pulmonary Arterial Hypertension
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What potential harms can be associated with Q4W GMA301 IV injections (300 mg)?
"Due to the lack of clinical data around this intervention, our Power team assessed Q4W GMA301 IV injections (300 mg) as a 1 on their safety scale. This is an early phase trial with limited evidence of both efficacy and safety."
What is the aggregate of participants taking part in this research?
"Affirmative. The information on clinicaltrials.gov confirms that this research endeavor, which was initially made public on October 22nd 2020 is actively recruiting volunteers. A total of 48 participants are required to be recruited from 4 different medical centres."
Are there numerous centers conducting this research within North America?
"Currently, 4 clinics are participating in the clinical trial. These include sites located in Louisville, Dallas and Boston amongst others. To reduce travel constraints when enrolling, we recommend selecting a medical centre near you."
Are enrollees still being accepted into this experiment?
"The clinical trial is presently recruiting patients, as noted by the information on clinicaltrials.gov that documents its initial posting date of October 22nd 2020 and last update from December 29th 2021."
Am I eligible to participate in this research study?
"In order to participate, patients must have pulmonary arterial hypertension and be between 18-75 years old. This study is recruiting 48 qualified individuals in total."
Does this clinical trial include participants above the age of fifty?
"The accepted age range for this trial is from 18 to 75 years of age. Notably, there are separate studies available for people under the legal age and those above 65."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger